Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment

SARS-CoV-2 is a novel β-coronavirus that caused the COVID-19 pandemic disease, which spread rapidly, infecting more than 134 million people, and killing almost 2.9 million thus far. Based on the urgent need for therapeutic and prophylactic strategies, the identification and characterization of antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Valdez-Cruz, Norma A., García-Hernández, Enrique, Espitia, Clara, Cobos-Marín, Laura, Altamirano, Claudia, Bando-Campos, Carlos G., Cofas-Vargas, Luis F., Coronado-Aceves, Enrique W., González-Hernández, Ricardo A., Hernández-Peralta, Pablo, Juárez-López, Daniel, Ortega-Portilla, Paola A., Restrepo-Pineda, Sara, Zelada-Cordero, Patricio, Trujillo-Roldán, Mauricio A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061467/
https://www.ncbi.nlm.nih.gov/pubmed/33888152
http://dx.doi.org/10.1186/s12934-021-01576-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061467/
https://www.ncbi.nlm.nih.gov/pubmed/33888152
http://dx.doi.org/10.1186/s12934-021-01576-5

Ejemplares similares